The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of selinexor, a first in class selective inhibitor of nuclear export (SINE) compound, in combination with doxorubicin in patients (pts) with locally advanced or metastatic soft tissue sarcoma (STS).
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Esmail al-Ezzi
No Relationships to Disclose
 
Abha A. Gupta
No Relationships to Disclose
 
Pernille Pedersen
No Relationships to Disclose
 
Dagmara Kolodziejczyk
No Relationships to Disclose
 
Ragitha Ellencherry
No Relationships to Disclose
 
Oulu Zhu
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Merck
Research Funding - Amgen; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CASI Pharmaceuticals; Deciphera; Karyopharm Therapeutics; Lilly; MedImmune; Novartis; Pfizer; Roche/Genentech
 
Jeremy Howard Lewin
No Relationships to Disclose